Search research articles
Contact Us
Filters
Showing results (41-50 of 139) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
Iris J H van Vlodrop, Hanneke E C Niessen, Sarah Derks, et al.
Epigenomics
|
March 28, 2012
Promoter CpG island methylation markers in colorectal cancer: the road ahead
Muriel X G Draht, Robert R Riedl, Hanneke Niessen, et al.
Clinical Epigenetics
|
April 28, 2016
Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
Muriel X G Draht, Kim M Smits, Valérie Jooste, et al.
International Journal of Cancer
|
December 13, 2016
Assessing opportunities for coordinated R&D in early cancer detection and management in Europe
Anton E Ussi, Matejka Rebolj, Mangesh A Thorat, et al.
International Journal of Cancer
|
September 22, 2016
Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study
Colinda C J M Simons, Leo J Schouten, Roger W Godschalk, et al.
World Journal of Gastrointestinal Oncology
|
November 28, 2022
Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
Manon van der Vlugt, Beatriz Carvalho, Joelle Fliers, et al.
Molecular and Cellular Biology
|
November 13, 2003
GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer
Yoshimitsu Akiyama, Neil Watkins, Hiromu Suzuki, et al.
Epigenomics
|
August 15, 2017
Prognostic DNA methylation markers for renal cell carcinoma: a systematic review
Sophie C Joosten, Ivette Ag Deckers, Maureen J Aarts, et al.
The Journal of Pathology. Clinical Research
|
August 18, 2025
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification
Selena Odeh, Iryna Samarska, Andres Matoso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 23, 2017
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening
Iris Lansdorp-Vogelaar, S Lucas Goede, Linda J W Bosch, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 139) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
Iris J H van Vlodrop, Hanneke E C Niessen, Sarah Derks, et al.
Epigenomics
|
March 28, 2012
Promoter CpG island methylation markers in colorectal cancer: the road ahead
Muriel X G Draht, Robert R Riedl, Hanneke Niessen, et al.
Clinical Epigenetics
|
April 28, 2016
Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
Muriel X G Draht, Kim M Smits, Valérie Jooste, et al.
International Journal of Cancer
|
December 13, 2016
Assessing opportunities for coordinated R&D in early cancer detection and management in Europe
Anton E Ussi, Matejka Rebolj, Mangesh A Thorat, et al.
International Journal of Cancer
|
September 22, 2016
Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study
Colinda C J M Simons, Leo J Schouten, Roger W Godschalk, et al.
World Journal of Gastrointestinal Oncology
|
November 28, 2022
Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
Manon van der Vlugt, Beatriz Carvalho, Joelle Fliers, et al.
Molecular and Cellular Biology
|
November 13, 2003
GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer
Yoshimitsu Akiyama, Neil Watkins, Hiromu Suzuki, et al.
Epigenomics
|
August 15, 2017
Prognostic DNA methylation markers for renal cell carcinoma: a systematic review
Sophie C Joosten, Ivette Ag Deckers, Maureen J Aarts, et al.
The Journal of Pathology. Clinical Research
|
August 18, 2025
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification
Selena Odeh, Iryna Samarska, Andres Matoso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 23, 2017
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening
Iris Lansdorp-Vogelaar, S Lucas Goede, Linda J W Bosch, et al.
Page
of 14